Supporting the role of NSD1 loss in ccRCC tumorigenesis, Yan and colleagues found in RCC samples (TCGA cohort) a much higher level of NSD1 amplification in over 10% of ccRCC samples which was associated with a significant prolonged survival [65]. The gene discussed is NSD1; the disease is nonpapillary renal cell carcinoma.